gabapentin has been researched along with mexiletine in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (50.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Atkinson, R; Carroll, W; Chapman, M; Chu, K; Drizin, I; Faltynek, CR; Gauvin, D; Gregg, R; Gross, M; Hakeem, A; Hernandez, G; Honore, P; Jarvis, MF; Johnson, M; Joshi, S; Kort, M; Krafte, DS; Krambis, M; Liu, D; Liu, Y; Marron, B; Marsh, K; Matulenko, M; McGaraughty, S; Mikusa, JP; Pai, M; Roeloffs, R; Scanio, M; Shi, L; Shieh, CC; Sullivan, JP; Thomas, J; Wade, C; Wagoner, PK; Zhang, XF; Zhong, C; Zhu, C | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Abbadie, C; Duffy, JL; Felix, JP; Garcia, ML; Hoyt, SB; Jochnowitz, N; Kaczorowski, GJ; Karanam, BV; Li, X; London, C; Lyons, KA; McGowan, E; Priest, BT; Smith, MM; Thomas-Fowlkes, BS; Warren, VA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barnaby, O; Bourin, C; Bristow, LJ; Bronson, J; Chen, P; Dzierba, C; Easton, A; Guernon, J; Herrington, J; Knox, RJ; Luo, G; Matchett, M; McClure, A; Meanwell, NA; Mosure, K; Newton, A; Ng, A; Olson, R; Parker, D; Pieschl, R; Rajamani, R; Sivarao, DV; Soars, MG; Thompson, LA; Wu, YJ | 1 |
Andoh, T; Kuraishi, Y; Nojima, H; Sasaki, A; Shiraki, K; Takasaki, I | 1 |
Fassoulaki, A; Hogan, Q; Patris, K; Sarantopoulos, C | 1 |
Maeda, K; Yasuda, H | 1 |
Abbadie, C; Anderson, HA; Clapp, RH; Delaney, A; Fleetwood-Walker, SM; Garry, EM; Kinchington, PR; Krah, DL; Martin, WJ; Sirinathsinghji, EC | 1 |
Csete, M; Klass, M | 1 |
Fürst, Z | 1 |
Kel, E; Ulu, ST | 1 |
Berner, R; Creutzfeldt, R; Hufnagel, M; Jakob, A; Staszewski, O; Winterpacht, A | 1 |
Chaparro, LE; Gilron, I; Moore, RA; Smith, SA; Wiffen, PJ | 1 |
Kaneko, S; Miyake, T; Nakagawa, T; Nakamura, S; Narita, M; Shirakawa, H; So, K; Tokuyama, S; Zhao, M | 1 |
Harada, S; Matsuura, W; Tokuyama, S | 1 |
Senet, P | 1 |
4 review(s) available for gabapentin and mexiletine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Symptomatic treatment of painful diabetic neuropathy].
Topics: Amines; Anti-Asthmatic Agents; Anticonvulsants; Antidepressive Agents; Antitussive Agents; Cyclohexanecarboxylic Acids; Dextromethorphan; Diabetic Neuropathies; Fructose; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Humans; Lamotrigine; Mexiletine; Nerve Fibers; Posterior Horn Cells; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Topiramate; Triazines | 2005 |
[Central and peripheral mechanisms in antinociception: current and future perspectives].
Topics: Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Tolerance; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Mexiletine; Nicotinic Agonists; Nociceptors; omega-Conotoxins; Pain; Pyridines; Receptors, Opioid; Sodium Channels | 2008 |
Pharmacotherapy for the prevention of chronic pain after surgery in adults.
Topics: Adrenal Cortex Hormones; Adult; Amines; Analgesics; Chronic Pain; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ibuprofen; Ketamine; Male; Mexiletine; Pain, Postoperative; Pregabalin; Randomized Controlled Trials as Topic | 2013 |
1 trial(s) available for gabapentin and mexiletine
Article | Year |
---|---|
The analgesic effect of gabapentin and mexiletine after breast surgery for cancer.
Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Antineoplastic Agents; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mexiletine; Middle Aged; Pain Measurement; Pain, Postoperative; Surveys and Questionnaires; Time Factors | 2002 |
15 other study(ies) available for gabapentin and mexiletine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Topics: Action Potentials; Analgesics; Aniline Compounds; Animals; Capsaicin; Evoked Potentials; Furans; Ganglia, Spinal; Humans; Inflammation; Kinetics; Male; Mononeuropathies; NAV1.8 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Neurons; Pain; Pain Management; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sodium Channel Blockers; Sodium Channels | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain.
Topics: Animals; Benzazepines; Disease Models, Animal; Neuralgia; Rats; Sodium Channel Blockers | 2013 |
Discovery of non-zwitterionic aryl sulfonamides as Na
Topics: Administration, Oral; Animals; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Freund's Adjuvant; HEK293 Cells; Humans; Inflammation; Male; Mice; Models, Biological; Molecular Structure; NAV1.7 Voltage-Gated Sodium Channel; Neurons; Nociception; Structure-Activity Relationship; Sulfonamides | 2017 |
Effects of analgesics on delayed postherpetic pain in mice.
Topics: Acetates; Acute Disease; Acyclovir; Amines; Analgesics; Analgesics, Opioid; Animals; Antiviral Agents; Behavior, Animal; Cyclohexanecarboxylic Acids; DNA, Viral; Female; Gabapentin; gamma-Aminobutyric Acid; Herpesviridae Infections; Herpesvirus 1, Human; Mexiletine; Mice; Mice, Inbred BALB C; Morphine; Pain; Pain Measurement; Physical Stimulation | 2002 |
Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs.
Topics: Amines; Animals; Anticonvulsants; Behavior, Animal; Cyclohexanecarboxylic Acids; Disease Models, Animal; Fluorescent Antibody Technique; Gabapentin; Galanin; gamma-Aminobutyric Acid; Ganglia, Spinal; Herpes Zoster; Herpesvirus 3, Human; Immediate-Early Proteins; Immunohistochemistry; Lamotrigine; Mexiletine; Neuralgia; Neuralgia, Postherpetic; Neurons, Afferent; Neuropeptide Y; Rats; Receptors, N-Methyl-D-Aspartate; Reflex; Sodium Channels; Trans-Activators; Triazines; Viral Envelope Proteins; Virus Latency | 2005 |
One from column A and one from column B: may I take your order?
Topics: Amines; Analgesics, Opioid; Anti-Arrhythmia Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Mexiletine; Morphine; Pain, Postoperative; Phantom Limb; Randomized Controlled Trials as Topic | 2008 |
Highly sensitive determination and validation of gabapentin in pharmaceutical preparations by HPLC with 4-fluoro-7-nitrobenzofurazan derivatization and fluorescence detection.
Topics: 4-Chloro-7-nitrobenzofurazan; Amines; Capsules; Chromatography, High Pressure Liquid; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hydrogen-Ion Concentration; Linear Models; Mexiletine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2011 |
Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Topics: Administration, Oral; Amines; Analgesics; Child; Cyclohexanecarboxylic Acids; Diagnosis, Differential; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromelalgia; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusions, Intravenous; Lidocaine; Male; Mexiletine; NAV1.7 Voltage-Gated Sodium Channel; Nitroprusside; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents | 2012 |
Pharmacological characterization of standard analgesics on oxaliplatin-induced acute cold hypersensitivity in mice.
Topics: Acute Disease; Amines; Analgesics; Animals; Antineoplastic Agents; Calcium Gluconate; Cryopyrin-Associated Periodic Syndromes; Cyclohexanecarboxylic Acids; Cyclopropanes; Gabapentin; gamma-Aminobutyric Acid; Male; Mexiletine; Mice; Mice, Inbred C57BL; Milnacipran; Morphine; Organoplatinum Compounds; Oxaliplatin; Tramadol | 2014 |
Effects of Adjuvant Analgesics on Cerebral Ischemia-Induced Mechanical Allodynia.
Topics: Amines; Analgesics; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain Ischemia; Carbamazepine; Chemotherapy, Adjuvant; Cyclohexanecarboxylic Acids; Cyclopropanes; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Imipramine; Indomethacin; Male; Mexiletine; Mice; Milnacipran; Morphine; Neuralgia; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2016 |
[Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management].
Topics: Antibodies, Antinuclear; Aspirin; Calcium Channel Blockers; Erythromelalgia; Gabapentin; Humans; Iloprost; Lidocaine; Mexiletine; Raynaud Disease; Small Fiber Neuropathy; Sodium Channel Blockers | 2022 |